TY - JOUR
T1 - Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase
AU - Anderson, K. E.
AU - Simionatto, C. S.
AU - Drummond, G. S.
AU - Kappas, A.
PY - 1984
Y1 - 1984
N2 - Tin(Sn)-protoporphyrin is a potent competitive inhibitor of heme oxygenase and can also suppress naturally occurring or experimentally induced hyperbilirubinemia in animals. In this study we examined the plasma clearance of Sn-protoporphyrin, its persistence in tissues and the time course of heme oxygenase inhibition up to 7 days after administration of doses up to 50 μmol/kg b.w. to adult male rats. After s.c. doses the metalloporphyrin was rapidly and almost completely absorbed. Initial plasma clearance was log-linear with a T 1/2 of approximately 3 h after either i.v. or s.c. administration. Levels of Sn-protoporphyrin in most tissues rose during the first 2 h and persisted for up to 7 days. Concentrations were highest in kidney and liver, were considerably lower in spleen, lung, intestine, adrenal and testes, and as Sn-protoporphyrin concentrations in plasma declined, concentrations in these tissues eventually exceeded simultaneous plasma concentrations. This suggests a varying degree of uptake and binding of the metalloporphyrin in these tissues. There was little or no uptake of Sn-protoporphyrin in heart, brain and red cells. Markedly decreased heme oxygenase activity in liver, kidney and spleen peristed as did Sn-protoporphyrin up to 7 days. The total mount of Sn-protoporphyrin present in tissues and excreta was a fairly constant fraction of the dose (~50%) at time intervals up to 7 days after injection. These results indicate that single doses of Sn-protoporpyrin are rapidly cleared from plasma and persist in tissues and potently inhibit heme oxygenase activity for prolonged periods.
AB - Tin(Sn)-protoporphyrin is a potent competitive inhibitor of heme oxygenase and can also suppress naturally occurring or experimentally induced hyperbilirubinemia in animals. In this study we examined the plasma clearance of Sn-protoporphyrin, its persistence in tissues and the time course of heme oxygenase inhibition up to 7 days after administration of doses up to 50 μmol/kg b.w. to adult male rats. After s.c. doses the metalloporphyrin was rapidly and almost completely absorbed. Initial plasma clearance was log-linear with a T 1/2 of approximately 3 h after either i.v. or s.c. administration. Levels of Sn-protoporphyrin in most tissues rose during the first 2 h and persisted for up to 7 days. Concentrations were highest in kidney and liver, were considerably lower in spleen, lung, intestine, adrenal and testes, and as Sn-protoporphyrin concentrations in plasma declined, concentrations in these tissues eventually exceeded simultaneous plasma concentrations. This suggests a varying degree of uptake and binding of the metalloporphyrin in these tissues. There was little or no uptake of Sn-protoporphyrin in heart, brain and red cells. Markedly decreased heme oxygenase activity in liver, kidney and spleen peristed as did Sn-protoporphyrin up to 7 days. The total mount of Sn-protoporphyrin present in tissues and excreta was a fairly constant fraction of the dose (~50%) at time intervals up to 7 days after injection. These results indicate that single doses of Sn-protoporpyrin are rapidly cleared from plasma and persist in tissues and potently inhibit heme oxygenase activity for prolonged periods.
UR - http://www.scopus.com/inward/record.url?scp=0021343014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021343014&partnerID=8YFLogxK
M3 - Article
C2 - 6546399
AN - SCOPUS:0021343014
SN - 0022-3565
VL - 228
SP - 327
EP - 333
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -